Thomas Malley sold $5.9M of Kiniksa Pharmaceuticals International (KNSA)

Executed Aug 12 2025, disclosed Aug 14 2025, 2 days later.

Value, as filed

$5.9M

177,769 sh across 3 lots

Executed

Aug 12 2025

the trade date, as filed

Disclosed

Aug 14 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Thomas Malley Director profile →

Thomas Malley (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $5.9M of KNSA (177,769 sh across 3 lots, as filed), executed Aug 12 2025.

The name

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 72 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→